PathoQuest

PathoQuest is a France-based company that provides clinical diagnostics and biological quality control testing services for the biopharmaceutical industry.

Business Model:

Revenue: $10M

Employees: 11-50

Detailed PathoQuest Information

Geographic Data

PathoQuest headquarters map

Address: 11 rue Watt

City: Paris

State: île-de-france

Zip: 75013

Country: FR

Financial Info

Stage:

series b

Raised Last:

$17M

Raised Total:

$28M

Metrics

8,482,179Website Global Rank

303Website Monthly Traffic

Twitter Followers

Description

PathoQuest is a France-based company that provides clinical diagnostics and biological quality control testing services for the biopharmaceutical industry.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
7/2013 Series B 3 $5M Kurma Partners
Idinvest Partners
Agrinvest
Kurma Partners
Idinvest Partners
Agrinvest
9/2019 Venture Round $0 Charles River Laboratories International
Careismatic Brands
Fraser
Idinvest Partners
Kurma Partners
Norgine Ventures
Verve Ventures
Charles River Laboratories International
Careismatic Brands
Fraser
Idinvest Partners
Kurma Partners
Norgine Ventures
Verve Ventures
3/2011 Series A 1 $2.8M Kurma Partners
Kurma Partners
7/2015 Venture Round $0 Kurma Partners
Aurinvest
Idinvest Partners
Kurma Partners
Aurinvest
Idinvest Partners
11/2021 Series B 8 $17.4M Verve Ventures
Turenne Capital
SHS Capital
Kurma Partners
Fraser
Eurazeo
Charles River Laboratories International
Agrinvest
Verve Ventures
Turenne Capital
SHS Capital
Kurma Partners
Fraser
Eurazeo
Charles River Laboratories International
Agrinvest
5/2018 Venture Round $0 Aurinvest
Fraser
Idinvest Partners
Kurma Partners
Aurinvest
Fraser
Idinvest Partners
Kurma Partners
11/2021 Series B $11.6M SHS Gesellschaft für Beteiligungsmanagement mbH
Turenne Groupe
Kurma Partners
Verve ventures
Eurazeo
Aurinvest
Charles River Laboratories
9/2019 Series A $8.8M Norgine Ventures
Kurma Partners
Idinvest
Charles River
investiere
7/2013 Series B $5M Idinvest Partners
Aurinvest
Kurma Life Science Partners
3/2011 Seed $2.8M
11/2021 Series B $0 Aurinvest
Charles River Laboratories International
Eurazeo
Kurma Partners
SHS Capital
Turenne Capital
Verve Ventures
Aurinvest
Charles River Laboratories International
Eurazeo
Kurma Partners
SHS Capital
Turenne Capital
Verve Ventures
11/2021 Series B 7 $17.4M Aurinvest
Charles River Laboratories International
Eurazeo
Kurma Partners
SHS Capital
Turenne Capital
Verve Ventures
Aurinvest
Charles River Laboratories International
Eurazeo
Kurma Partners
SHS Capital
Turenne Capital
Verve Ventures
9/2019 Venture Round 7 $8.9M Careismatic Brands
Charles River Laboratories International
Fraser
Idinvest Partners
Kurma Partners
Norgine Ventures
Verve Ventures
Careismatic Brands
Charles River Laboratories International
Fraser
Idinvest Partners
Kurma Partners
Norgine Ventures
Verve Ventures
5/2018 Venture Round 4 $4.7M Aurinvest
Fraser
Idinvest Partners
Kurma Partners
Aurinvest
Fraser
Idinvest Partners
Kurma Partners
7/2015 Venture Round 3 $2.2M Kurma Partners
Kurma Partners
7/2013 Series B 3 $5M Kurma Partners
Kurma Partners
3/2011 Series A 1 $2.8M Kurma Partners
Kurma Partners
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research